( More than half of all men over age 60 s...)Two drugs Mays Be Better Than One For Prostate Enlargement,Health
Navigation Links
Two drugs Mays Be Better Than One For Prostate Enlargement
More than half of all men over age 60 suffer from a non-cancerous enlargement of the prostate called BPH. BPH causes // lower urinary tract symptoms, and those symptoms are frequent urination, nighttime urination, difficulty starting the stream, interrupting the stream, incomplete emptying of the bladder, etc.Based on the findings of a recent study researchers say two drugs may be better than one when it comes to treating this condition.
Researchers tested a combination of two drugs -- Proscar and Cardura -- to help the condition. 67 percent of more than 3,000 men in the five-year study were helped by the combination therapy.Researchers believe this therapy is a long-term treatment and could help many men avoid surgery.Specialists says a few men did experience side effects but none were dangerous, and they went away after the patient stopped taking the drugs.
Recent studies also show one of the drugs, Proscar, also known as finasteride, can reduce the risk of prostate cancer in some men.
'"/>
Related medicine news :
1. Cancer drugs in development nearly doubled since 1995
2. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
3. African HIV strains more resistant to anti HIV drugs
4. Right drugs drastically cut stroke risk
5. Relating heart protection and antihypertensive drugs
6. Enzyme may be target for obesity drugs
7. New HIV cases resist drugs
8. Relief to pregnant women using fertility drugs
9. AIDS drugs linked to heart attack risk
10. FDA debates status of decongestant drugs
11. Status of some prescription drugs
Post Your Comments:
(Date:10/3/2008)...- Inc. Magazine recently included,Connolly Consult...ing,private companies in the country. The list is ...segment of the economy -- America,s,independent-mi...ies,represent the backbone of the U.S. economy., ...03/NY36880LOGO ), Connolly Consulting,s consiste...
(Date:10/3/2008)... Discrimination; Recognizes,Importance of Mental H.../PRNewswire-USNewswire/ -- Mental Health,America t...approval of a,mental health parity legislation tha...ion against Americans with mental health and subst...lans., The legislation, which recognizes the impo...
(Date:10/3/2008)...search Foundation(R) Collection of, Bouquets to T...Research, LOS ANGELES, Oct. 3 /PRNewswire/ -- Tel...g only hand-arranged, hand-delivered floral,arrang...nth-long,collaboration with The City of Hope, John... Cancer Center in southern California and national...
(Date:10/3/2008)...- As the population ages, a big,question employers...e the,financial crunch of an illness?", In most c...eck to,paycheck and now need two incomes to provid... spouses becomes critically ill and unable to work...ut the healthy,employee/spouse is strained by the ...
Breaking Medicine News(10 mins):Health News:Connolly Consulting Makes the 2008 Inc. Magazine's List of America's 5000 Fastest Growing Companies 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 3Health News:Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer 2Health News:Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer 3Health News:Can Your Employees Survive the Financial Crunch of an Illness? 2[0] Connolly Consulting Makes the 2008 Inc. Magazine's List of America's 5000 Fastest Growing Companies[0] Mental Health America Hails Approval of Federal Parity Legislation[0] Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer[0] Can Your Employees Survive the Financial Crunch of an Illness?
...scientists from British Cardiac Society, the Briti...e Primary Care Cardiovascular Society // and the ...idelines for preventing cardiovascular risks of he.... The new guidelines is drafted to reduce the risk...
...tish Medical Journal it was said that people in Lo.../ . Money cannot bring you all the comforts and h...g the relationships that a happy and long life can...als usually get richer during their lifetimes – bu...
... Health & Science University and the University of...ct molecular mixture present in male-emitted phero...ity and increased aggression) dictates the sexual ...ompetitors and influences the female elephants mat...
...robably rosy picture of coma patients' survival an...s for viewers // , says a study. Tracking storylin...hers found that soap opera patients were far more ...e. And they were also much more likely to emerge u...
Other Medicine News:Health News:Happiness Is Not Attained By A Wealthy Life But By A Healthy One. 2Health News:The Chemistry Of Sexual Attraction Between Male And Female Elephants 2(Date:10/6/2008)...G Annual Scientific Conference -, ORLANDO, Fla., ...ormerly Microbia) today announced presentation of ...g the role that cyclic guanosine,monophosphate (cG...udies,demonstrate that cGMP inhibits intestinal pa...ia and desensitizes colonic afferent nerves in a,s...
(Date:10/6/2008)...Collaborate to Improve Patient Safety, WASHINGTON...ollege of,Cardiology in collaboration with the Ame... Heart Association today released consensus guidel...e risk of ulcers and,gastrointestinal (GI) bleedin...ory drugs (NSAIDs) along with antiplatelet agents....
(Date:10/6/2008)...s with Durezol Dosed Prior to Surgery, TAMPA, Fla...., a,privately held ophthalmic-focused biopharmace...difluprednate ophthalmic emulsion) 0.05% is now,co...by the U.S. Food and,Drug Administration in June 2...ted for the treatment of inflammation and pain ass...
(Date:10/6/2008)... /- Genaera,Corporation (Na...Phase 1,clinical trial of trodusquemine (MSI-1436)...of type 2 diabetes and obesity. MSI-1436 is a nove... that controls the function,of both the leptin and...e,appetite. In the study, MSI-1436 was found to be...
Breaking Medicine Technology:Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Manure management reduces levels of antibiotics and antibiotic resistance genes 1369 1Manure management reduces levels of antibiotics and antibiotic resistance genes 1369 2Obesity Rates Leveling Off Among U S Adults 7141 1Obesity Rates Leveling Off Among U S Adults 7141 2Reduce Stress Hormones to Beat Sleep Problems 7139 1Reduce Stress Hormones to Beat Sleep Problems 7139 2Study Finds High Cost of Caring for Aging Parent 7137 1Study Finds High Cost of Caring for Aging Parent 7137 2[0] Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain[0] Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use[0] Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain[0] Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
...ares favorably with,the activity of mTOR inhibitor...tCall/ - AEterna,Zentaris Inc. , a global biopharm... oncology, today announced that its partner,Keryx...hase 1 and,Phase 2 results for perifosine, an oral...d, for the treatment of patients with,advanced sar...
... Breast Cancer,Growth By 75%, DALLAS and IRVINE, C...ess Pharmaceuticals, Inc. (Bulletin Board: ACCP) a...SMPM) announced today that a,scientific abstract o...,s Angiolix has been selected for publication in t...nical Oncology,(ASCO) Annual Meeting to be held in...
Other Medicine Technology:AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 2AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 3AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 4Access and Somanta Announce Data to be Presented on Angiolix at,ASCO Oncology Conference 2Access and Somanta Announce Data to be Presented on Angiolix at,ASCO Oncology Conference 3| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |